US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 18.000
- +0.270+1.52%
Close Nov 1 16:00 ET
- 18.000
- 0.0000.00%
Post 20:02 ET
486.76MMarket Cap-6691P/E (TTM)
18.358High17.500Low317.94KVolume18.090Open17.730Pre Close5.72MTurnover1.28%Turnover RatioLossP/E (Static)27.04MShares45.00052wk High1.88P/B445.61MFloat Cap17.50052wk Low--Dividend TTM24.76MShs Float129.710Historical High--Div YieldTTM4.84%Amplitude4.110Historical Low17.981Avg Price1Lot Size
Arcturus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 380.67%45.98M | -59.11%32.6M | -23.33%157.75M | -84.33%25.08M | 224.45%43.38M | -64.70%9.57M | 1,420.39%79.73M | 1,564.82%205.76M | 2,662.32%160.05M | 448.58%13.37M |
| Operating revenue | 380.67%45.98M | -59.11%32.6M | -23.33%157.75M | -84.33%25.08M | 224.45%43.38M | -64.70%9.57M | 1,420.39%79.73M | 1,564.82%205.76M | 2,662.32%160.05M | 448.58%13.37M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 3.33%67.1M | -3.02%63.01M | 21.89%235.95M | 12.31%43.35M | 24.94%62.69M | 32.04%64.94M | 16.81%64.97M | -10.05%193.58M | -11.15%38.6M | -10.81%50.18M |
| Selling and administrative expenses | -6.87%12.32M | 7.91%14.85M | 14.76%52.87M | 5.46%12.51M | 7.12%13.38M | 20.30%13.23M | 28.26%13.76M | 11.15%46.07M | 9.75%11.86M | 14.99%12.49M |
| -General and administrative expense | -6.87%12.32M | 7.91%14.85M | 14.76%52.87M | 5.46%12.51M | 7.12%13.38M | 20.30%13.23M | 28.26%13.76M | 11.15%46.07M | 9.75%11.86M | 14.99%12.49M |
| Research and development costs | 11.39%58.67M | 3.49%53.57M | 30.04%192.13M | 35.73%36.62M | 35.53%51.08M | 37.91%52.67M | 15.31%51.77M | -14.97%147.75M | -17.32%26.98M | -16.98%37.69M |
| Other operating expenses | -307.02%-3.88M | -873.74%-5.41M | -3,609.43%-9.05M | ---5.78M | ---1.76M | ---954K | ---556K | ---244K | ---- | ---- |
| Operating profit | 61.85%-21.13M | -306.11%-30.41M | -742.24%-78.21M | -115.04%-18.27M | 47.53%-19.31M | -150.69%-55.37M | 129.29%14.76M | 106.00%12.18M | 422.62%121.45M | 31.61%-36.81M |
| Net non-operating interest income expense | 27.55%4.15M | 62.13%4.02M | 4,050.48%16.59M | 571.41%6.88M | 1,340.19%3.98M | 680.71%3.25M | 539.18%2.48M | 78.14%-420K | 295.61%1.03M | 38.15%-321K |
| Non-operating interest income | 27.55%4.15M | 24.72%4.02M | 572.57%17.36M | 279.39%6.89M | 801.13%4M | 1,835.71%3.25M | 1,990.91%3.22M | --2.58M | --1.82M | 131.25%444K |
| Non-operating interest expense | --0 | --0 | -74.44%767K | -99.49%4K | -97.39%20K | --0 | 3.48%743K | --3M | --790K | 7.59%765K |
| Other net income (expense) | -360.40%-388K | -100.16%-53K | 3,130.01%33.72M | 98.59%-54K | -99.79%4K | -86.28%149K | 14,978.32%33.63M | -201.27%-1.11M | -676.32%-3.84M | 627.34%1.86M |
| Gain on sale of security | -360.40%-388K | 83.84%-53K | 61.71%-229K | 98.59%-54K | -99.79%4K | -87.76%149K | -307.59%-328K | -202.40%-598K | -1,031.27%-3.84M | 267.98%1.86M |
| Earnings from equity interest | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -200.00%-515K | --0 | --0 |
| Special income (charges) | --0 | --0 | --33.95M | --0 | --0 | --0 | --33.95M | --0 | --0 | --0 |
| -Less:Other special charges | ---- | ---- | ---33.95M | --0 | ---- | ---- | ---33.95M | ---- | ---- | ---- |
| Income before tax | 66.59%-17.37M | -152.01%-26.45M | -362.03%-27.89M | -109.65%-11.45M | 56.53%-15.33M | -141.03%-51.97M | 199.39%50.86M | 105.23%10.64M | 406.86%118.64M | 34.79%-35.27M |
| Income tax | -126.00%-150K | 257.28%368K | 41.70%1.84M | -79.77%262K | 893K | 577K | 103K | 1.3M | 1.3M | 0 |
| Net income | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M | 34.79%-35.27M |
| Net income continuous Operations | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M | 34.79%-35.27M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M | 34.79%-35.27M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 67.24%-17.22M | -152.84%-26.82M | -417.95%-29.73M | -109.98%-11.71M | 54.00%-16.22M | -143.70%-52.55M | 199.19%50.75M | 104.59%9.35M | 403.51%117.35M | 34.79%-35.27M |
| Basic earnings per share | 67.68%-0.64 | -152.36%-1 | -420.00%-1.12 | -107.22%-0.32 | 54.14%-0.61 | -141.46%-1.98 | 198.45%1.91 | 104.52%0.35 | 401.36%4.43 | 35.12%-1.33 |
| Diluted earnings per share | 67.68%-0.64 | -153.48%-1 | -420.00%-1.12 | -107.22%-0.32 | 54.14%-0.61 | -141.46%-1.98 | 196.39%1.87 | 104.52%0.35 | 401.36%4.43 | 35.12%-1.33 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data